Showing results (1081-1090 of 30,290) with videos related to
Sort By:
Pageof 3,029
Drug Intelligence & Clinical Pharmacy|July 1, 1986
Sedative/hypnotic dependence: patient stabilization, tolerance testing, and withdrawalP J Perry, B AlexanderMaterials (Basel, Switzerland)|August 5, 2017
Roles of Bulk and Surface Chemistry in the Oxygen Exchange Kinetics and Related Properties of Mixed Conducting Perovskite Oxide ElectrodesNicola H Perry, Tatsumi IshiharaCanadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|December 8, 2015
Taking action: An exploration of the actions of exemplary oncology nurses when there is a sense of hopelessness and futility perceived by registered nurses at diagnosis, during treatment, and in palliative situationsKatherine J Janzen, Beth PerryJournal of Sex Research|December 16, 2017
Race and Trends in Pornography Viewership, 1973-2016: Examining the Moderating Roles of Gender and ReligionSamuel L Perry, Cyrus SchleiferRoyal Society Open Science|February 8, 2018
Correction to 'Walking with wider steps changes foot placement control, increases kinematic variability and does not improve linear stability'Jennifer A Perry, Manoj SrinivasanThe Journal of the Association of Nurses in AIDS Care : JANAC|January 15, 2018
A Systematic Review of Health Care Provider-Perceived Barriers and Facilitators to Routine HIV Testing in Primary Care Settings in the Southeastern United StatesKelly Tan, Beth Perry BlackNutrients|March 29, 2018
Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in NeurodegenerationElena L Paley, George PerryOphthalmic Plastic and Reconstructive Surgery|July 21, 2009
Superiorly based bilobed flap for inferior medial canthal and nasojugal fold defect reconstructionJulian D Perry, Mehryar TabanWorld Journal of Gastroenterology|April 3, 2009
Clostridium difficile associated infection, diarrhea and colitisPerry Hookman, Jamie S BarkinClinical Advances in Hematology & Oncology : H&O|September 17, 2005
The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspectiveWilliam L Perry, Aaron WeitzmanPageof 3,029